Skip to main content

Animations

MJFF Publications

6181 - 6190 of 9039 Results
Title
Year
  • Year
  • 2024
  • 2022
  • 2024
  • 2020
  • 2020
  • 2024
  • 2024
  • 2024
  • 2024
  • 2024
  • Summary Details
    OPEN
    Title: Biological Staging of the Parkinson’s Progression Markers Initiative (PPMI) Cohort Using the Research Neuronal α-synuclein Disease Integrated Staging System (NSD-ISS) (P11-3.009)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.0000000000204771
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Collaboration and knowledge integration for successful brain therapeutics – lessons learned from the pandemic
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.049755
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Real-World Experiences of Parkinson's Disease OFF Time and Role of Demographics
    Journal Name: Journal of Patient-Centered Research and Reviews
    Publisher: Aurora Health Care, Inc.
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.17294/2330-0698.2057
    Citation Count: 4
  • Summary Details
    OPEN
    Title: MRI-visible perivascular spaces are associated with cerebrospinal fluid biomarkers in Parkinson’s disease
    Journal Name: Aging
    Publisher: Impact Journals, LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.18632/aging.104200
    Citation Count: 29
  • Summary Details
    RESTRICTED
    Title: Investigating lymphocyte populations in patients with Parkinson’s disease
    Journal Name: Annals of Translational Medicine
    Publisher: AME Publishing Company
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.21037/atm.2020.02.29
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Levodopa-induced dyskinesia in Parkinson's disease: Insights from cross-cohort prognostic analysis using machine learning
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2024.107054
    Citation Count: 7
  • Summary Details
    OPEN
    Title: Parkinson's disease: Still waiting for a cure
    Journal Name: Clinical and Translational Science
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1111/cts.13898
    Citation Count: 1
  • Dual-task gait has prognostic value for cognitive decline in Parkinson’s disease
    2024
    Summary Details
    RESTRICTED
    Title: Dual-task gait has prognostic value for cognitive decline in Parkinson’s disease
    Journal Name: Journal of Clinical Neuroscience
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.jocn.2024.06.006
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Biochemical and neurophysiological effects of deficiency of the mitochondrial import protein TIMM50
    Journal Name: eLife
    Publisher: eLife Sciences Publications, Ltd
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.7554/elife.99914.3
    Citation Count: 1
  • Summary Details
    OPEN
    Title: A genetic and proteomic comparison of key AD biomarkers across tissues
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/alz.14139
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.